Cargando…
Investigating the Thioredoxin and Glutathione Systems’ Response in Lymphoma Cells after Treatment with [Au(d2pype)2]Cl
Lymphoma is a blood cancer comprising various subtypes. Although effective therapies are available, some patients fail to respond to treatment and can suffer from side effects. Antioxidant systems, especially the thioredoxin (Trx) and glutathione (GSH) systems, are known to enhance cancer cell survi...
Autores principales: | Wang, Sicong, Lu, Yaoying, Woods, Kyra, Di Trapani, Giovanna, Tonissen, Kathryn F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828567/ https://www.ncbi.nlm.nih.gov/pubmed/33451071 http://dx.doi.org/10.3390/antiox10010104 |
Ejemplares similares
-
Modulating skin colour: role of the thioredoxin and glutathione systems in regulating melanogenesis
por: Lu, Yaoying, et al.
Publicado: (2021) -
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
por: Clapper, Erin, et al.
Publicado: (2020) -
Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer
por: Raninga, Prahlad V., et al.
Publicado: (2014) -
Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma
por: Wang, Sicong, et al.
Publicado: (2023) -
Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
por: Raninga, Prahlad V., et al.
Publicado: (2015)